Medications
New study offers hope for weight loss drugs against alcoholism
Reported by AI Image generated by AI
A new study from the University of Gothenburg shows that tirzepatide, the active ingredient in the diabetes and weight loss drug Mounjaro, reduces alcohol intake and relapse-like behaviors in rats and mice. This builds on prior research on semaglutide in Ozempic and Wegovy, which curbs alcohol consumption in humans. Researchers hope for similar effects in patients with alcohol dependence.
Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.
Reported by AI
Colombia's Ministry of Health and Social Protection warned about the risks of excessive acetaminophen consumption among minors, known as the “acetaminophen challenge”. This social media-influenced practice leads to overdoses and severe liver and kidney damage.
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency have approved lenacapavir as pre-exposure prophylaxis (PrEP) for uninfected individuals at high risk. This antiretroviral drug is administered via subcutaneous injections every six months, providing an alternative to daily pills. The World Health Organization endorses its use in comprehensive prevention strategies.
Reported by AI
In chile's presidential runoff, candidates like Jeannette Jara have revived ideas to eliminate vat on drugs and end oncology waiting lists. These proposals aim to ease the high cost of medications, which accounts for 60% of out-of-pocket health spending. Experts see a chance for agreements that go beyond the election.